World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
102
Citations
42495
World Ranking
1350
National Ranking
18

Medicine

D-Index
102
Citations
42708
World Ranking
7602
National Ranking
256

Overview

Paolo Ghia is affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily focuses on medicine with significant contributions in genetics, pathology and forensic medicine, hematology, immunology, and oncology.

The scientist's main topics of work include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Advanced Breast Cancer Therapies
  • CAR-T cell therapy research
  • Gastrointestinal Tumor Research and Treatment

Paolo Ghia has authored numerous papers, including the following recent publications:

  • "The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee," 2022, published in Blood
  • "Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia," 2021, published in Blood
  • "Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial," 2020, published in The Lancet
  • "Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial," 2021, published in Journal of Clinical Oncology
  • "Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up," 2020, published in Annals of Oncology

Frequent co-authors in Paolo Ghia's work include Lydia Scarfò, Wojciech Jurczak, Constantine S. Tam, Κώστας Σταματόπουλος, and Alessandra Tedeschi. These collaborations reflect a network of professionals contributing to hematology and cancer research.

The primary publication venues where Paolo Ghia's work appears are:

  • Blood
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Hematological Oncology

Best Publications

  • Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

    Richard R. Furman;Jeff P. Sharman;Steven E. Coutre;Bruce D. Cheson

  • Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

    Jan A. Burger;Alessandra Tedeschi;Paul M. Barr;Tadeusz Robak

  • Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

    John C. Byrd;Bonnie Harrington;Susan O'Brien;Jeffrey A. Jones

  • Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.

    Kirsten Fischer;Jasmin Bahlo;Anna Maria Fink;Valentin Goede

  • The microenvironment in mature B-cell malignancies: a target for new treatment strategies

    Jan A. Burger;Paolo Ghia;Andreas Rosenwald;Federico Caligaris-Cappio

  • Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

    Luisa Granziero;Paolo Ghia;Paola Circosta;Daniela Gottardi

  • Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations

    Kostas Stamatopoulos;Chrysoula Belessi;Carol Moreno;Myriam Boudjograh

  • Diagnostic criteria for monoclonal B-cell lymphocytosis.

    Gerald E. Marti;Andy C. Rawstron;Paolo Ghia;Peter Hillmen

  • Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia.

    Yair Herishanu;Irit Avivi;Anat Aharon;Gabi Shefer

  • Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial

    Jeff P Sharman;Miklos Egyed;Wojciech Jurczak;Alan Skarbnik;Alan Skarbnik

  • International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

    A C Rawstron;N Villamor;M Ritgen;S Böttcher

  • Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

    Andreas Agathangelidis;Nikos Darzentas;Anastasia Hadzidimitriou;Xavier Brochet

  • B-cell clones as early markers for chronic lymphocytic leukemia.

    Ola Landgren;Maher Albitar;Wanlong Ma;Fatima Abbasi

  • Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

    Jan A. Burger;Paul M. Barr;Tadeusz Robak;Carolyn Owen

  • Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

    Fiona Murray;Nikos Darzentas;Anastasia Hadzidimitriou;Gerard Tobin

  • Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.

    John C Byrd;Peter Hillmen;Paolo Ghia;Arnon P Kater

  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

    P Baliakas;A Hadzidimitriou;L-A Sutton;D Rossi

  • Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.

    Paolo Ghia;Giuliana Strola;Luisa Granziero;Massimo Geuna

  • Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.

    Anthony R Mato;Nirav N Shah;Wojciech Jurczak;Chan Y Cheah

  • The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

    Ian W. Flinn;Peter Hillmen;Marco Montillo;Zsolt Nagy

Frequent Co-Authors

Kostas Stamatopoulos
Kostas Stamatopoulos Centre for Research and Technology Hellas
Richard Rosenquist
Richard Rosenquist Karolinska Institute
Federico Caligaris-Cappio
Federico Caligaris-Cappio Vita-Salute San Raffaele University
Šárka Pospíšilová
Šárka Pospíšilová Masaryk University
Frederic Davi
Frederic Davi Assistance Publique – Hôpitaux de Paris
Peter Hillmen
Peter Hillmen St James's University Hospital
David Oscier
David Oscier Royal Bournemouth Hospital
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Stephan Stilgenbauer
Stephan Stilgenbauer University of Ulm
Steven Coutre
Steven Coutre Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students fascinated by Biology and Biochemistry, exploring related online degrees can open doors to rewarding careers in healthcare, research, and administration. Many universities now offer flexible online programs that let you specialize and advance in your field.

If you are interested in healthcare management, consider reviewing the number of cahme accredited mha programs available online. These programs prepare you for leadership roles in hospitals and other medical settings.

For those looking to advance clinical skills without relocating, there are also best online dnp programs that do not require traditional clinical placements. Academic pathways in administration are equally accessible, with options to earn a doctorate in healthcare administration online.

If your interests lean toward pharmaceuticals, pursuing your studies at a best online pharmacy school can set you on the path to becoming a pharmacist or pharmaceutical scientist. These varied online opportunities empower you to align your Biology or Biochemistry background with a wide range of professional possibilities.

Best Scientists Citing Paolo Ghia

Trending Scientists

Recently Published Articles